BioCentury
ARTICLE | Clinical News

Collagenase Santyl ointment data

December 11, 1995 8:00 AM UTC

BSTC completed clinical trials in Italy for the re-registration of its collagenase ointment, which is marketed in the U.S. New trials were necessary to reintroduce the product in Italy after BSTC's agreement with its prior marketing partner, Knoll, ended in 1992. Licensee Istoria Farmaceutici S.p.A. expects to apply for marketing approval in January. ...